Particulate Quality of Single-Use Filling Systems - The author looks at strategies to minimize particle levels in the finished product when using single-use technologies downstream of final capabiliti


Particulate Quality of Single-Use Filling Systems
The author looks at strategies to minimize particle levels in the finished product when using single-use technologies downstream of final capabilities.

BioPharm International
Volume 24, Issue 7, pp. 20-24

Sterile connectors and disconnectors

Sterile connectors and disconnectors are often employed downstream of final sterilizing filters and could potentially contribute particles from the fluid path into final dosage containers. To control this risk, suppliers should sample and inspect molded parts for visible particulates upon receipt, and may also subject samples of assembled connectors and disconnectors to rinse analysis for microscopic particulates. Sterile connectors and disconnectors should be validated to not be significant sources of particles during actuation. When installed on single-use systems, sterile connectors and disconnectors can again be screened for visible particulates. Optically-clear connectors and disconnectors can facilitate the observation of visible particles that may be in the fluid path.

Tubing and fittings

Tubing and fittings are typically not manufactured with specific claims for particulate cleanliness. However, as with biocontainer films, their manufacturing processes (i.e., extrusion and molding) are not intrinsically particle generating, and particulate contamination can be minimized if manufactured and packaged under controlled, clean conditions. Incoming tubing and fittings from qualified suppliers can be screened for visible particles on a sampling basis, and then rescreened more thoroughly during assembly into single-use systems. Visual inspection for particles within tubing and fittings can be limited, however, by translucency or opacity of the tubing material. Additional testing for particulates in lot samples of tubing and fittings may be performed as part of the quality control procedures for assembled single-use systems.

Assembled single-use systems

Even where particulate matter in single-use components is minimized, there remains a risk for particles entering the fluid path from the cutting of tubing and insertion of hosebarbs into tubing. Systems can be assembled in a Class 10,000 cleanroom, but tube cutting and assembly methods should also be qualified by the supplier to demonstrate that visible particles are not generated and introduced into the fluid path during system assembly.

To assess the particulate quality of assembled tubing systems, some system suppliers have established quality-control programs where single-use system lot samples, or master systems with "worst case" tubing connections and component combinations, are subjected to rinse fluid analysis for particles. Results can demonstrate that the fluid path rinse fluids meet USP <788> limits for microscopic particles and quantify any visible particles detected.

Plug-and-play versus pre-use flush

Many drug developers have embraced the plug-and-play concept of single-use systems to mean that pre-use flushing of the fluid path can also be eliminated. Whether or not flushing of single-use final filtration and/or filling systems is required to minimize particles in the fluid path must be determined by the end user, as defined by process requirements for drug product quality. Where flushing with water for injection or buffer is desired, systems can be designed with flush collection bags and protocols to minimize residual fluid path hold-up volumes that could dilute initial drug product effluent. Where sterilizing filters are installed, this same procedure can be applied for wetting the filter before pre-use integrity testing, an increasing requirement for the marketing of drug products to some European countries. Alternatively, where appropriate, filters and the downstream fluid path can be flushed with product to minimize losses. Sterilized sterilizing grade filters can be pre-use integrity tested "product wet" with the flush going to initial filled containers that may be used for quality control weight/volume checks or formulation analysis. In that way, initial flush can be accommodated to minimize particles without separate loss of product.

Particulate quality of post-filtration single-use system fluid paths for final filtration and filling should be considered as part of design requirements. Assessments of recoverable particle sizes and levels should be made in advance of clinical and GMP production.

If you are considering single-use disposable systems for final filling or any other applications, please email me your questions or suggestions for future Disposable Advisor topics.

Jerold Martin is senior vice-president of Global Scientific Affairs at Pall Life Sciences, Port Washington, NY, and chairman of the Board and Technology Committee at Bio-Process Systems Alliance, tel. 516.801.9086.

blog comments powered by Disqus



Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here